Skip to content
Home/Companies/Biotech/TARA Biosystems

TARA Biosystems

Biotech·US·Exited 2022·Held 3yr
Entry
2019
Hold
3yr
Exit
2022

Who owns TARA Biosystems?

TARA Biosystems is an American Biotech company, now owned by Valo Health, which acquired it in 2022 from Merieux Equity Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Innovation 1 · 2014 · VC

Key facts

HQUS
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Valo Health
Exit Year
2022

More from Mérieux Innovation 1

Other portfolio companies in the same fund.

Broken String Biosciences
Broken String Biosciences
Active
BiotechUK· 2023
InnoSyn
InnoSyn
Active
PharmaNetherlands· 2023
LabQuality
LabQuality
Exited 2025
HealthcareFrance· 2023
to Aurevia
Cairdac
Cairdac
Active
MedTechFrance· 2022
Mablink Bioscience
Exited 2023
BiotechFrance· 2022
to Eli Lilly and Company
SeqOne Genomics
SeqOne Genomics
Active
BiotechFrance· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns TARA Biosystems?

TARA Biosystems is now owned by Valo Health, which acquired it in 2022 from Merieux Equity Partners.

When did Valo Health acquire TARA Biosystems?

Valo Health acquired TARA Biosystems in 2022, buying from Merieux Equity Partners.

Who did TARA Biosystems sell to?

Merieux Equity Partners sold TARA Biosystems to Valo Health in 2022 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue